|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Cost of goods sold | ||
| Gross profit | ||
| Selling expense | ||
| General and administrative expense | ||
| Net impairment losses on financial assets | ||
| Fair value loss on sale of accounts receivable, net | ||
| Other operating income | ||
| Operating income | ||
| Finance cost, net | ||
| Income from associate | ||
| Foreign exchange (loss)/gain, net | ||
| Derivative financial instrument gain/(loss), net | ||
| Other non-operating income | ||
| Income before income taxes | ||
| Income tax expense | ||
| Net income | ||
| Earnings per share of common stock: | ||
| Basic earnings per share (in usd per share) | ||
| Diluted earnings per share (in usd per share) | ||
| Weighted average number of common stock - basic (in shares) | ||
| Weighted average number of common stock - diluted (in shares) |
Loading...
